首頁 > 市場調查報告書 > 醫療設備

心血管設備

市場調查報告書

商品編碼

1550646

冠狀動脈繞道手術手術市場：依技術、依產品、依最終用戶、按地區

Coronary Artery Bypass Grafting Market, By Technology, By Product, By End User, By Geography

出版日期: 2024年08月05日 | 出版商:

Coherent Market Insights | 英文 165 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

預計2024年全球冠狀動脈繞道手術手術市場規模為140.2億美元，預計2031年將達261.5億美元，2024年至2031年複合年成長率為9.3%。

報告範圍		報告詳情
基準年	2023年	2024年市場規模	140.2億美元
實際資料	2019-2023	預測期	2024年至2031年
預測 2024-2031 年複合年成長率：	9.30%	2031年價值預測	261.5億美元

圖：2024 年按地區分類的冠狀動脈繞道手術手術市場佔有率(%)

冠狀動脈繞道手術手術（CABG）是一種改善心臟血流的手術。 CABG 用於治療其他治療方法不足以治療的嚴重冠狀動脈疾病。手術的主要目標是用健康的血管（通常來自患者的胸部、手臂或腿部）繞過狹窄或阻塞的冠狀動脈。這可以改善心肌的血流量和氧氣供應，緩解胸痛和胸悶（心絞痛）的症狀，並降低心臟病發作的風險。冠狀動脈繞道手術手術是全世界最常進行的心血管手術之一。

市場動態：.

冠狀動脈繞道手術手術的全球市場成長是由新興市場和已開發市場心臟病盛行率不斷上升所推動的。高血壓、糖尿病、肥胖和缺乏運動正在增加心血管疾病患者的數量，並推動了冠狀動脈繞道手術的需求。已開發國家對心臟治療的優惠報銷政策和新興經濟體醫療旅遊業的成長可以為市場成長提供機會。然而，冠狀動脈重組的創新微創血管內治療方法的市場開拓可能會阻礙市場成長，因為與心臟直視手術相比，它們的併發症更少，恢復更快。市場參與企業可以透過整合機器人技術和導航技術來克服這一限制，使 CABG 更安全、更簡單。

本研究的主要特點

本報告對全球冠狀動脈繞道手術手術市場進行了詳細分析，包括以2023年為基準年的預測期（2024-2031年）的市場規模（十億美元）和年複合成長率（CAGR%）。做。

它還揭示了各個細分市場的潛在商機，並為該市場說明了一系列有吸引力的投資提案。

它還提供了有關市場促進因素、限制因素、機會、新產品發布和核准、市場趨勢、區域前景、主要企業採取的競爭策略等的重要見解。

根據公司亮點、產品系列、主要亮點、績效和策略等參數，包括全球冠狀動脈繞道手術手術市場的主要企業概況。

主要企業包括美敦力 (Medtronic)、泰爾茂 (Terumo)、MAQUET、波士頓科學 (Boston Scientific)、CR Bard、Edwards Lifesciences 等。

從這份報告中獲得的見解將幫助負責人和公司經營團隊就未來的產品發布、升級、市場擴張和行銷策略做出明智的決策。

全球冠狀動脈繞道手術手術市場報告迎合了該行業的各種相關人員，如投資者、供應商、產品製造商、經銷商、新進業者和財務分析師。

透過用於分析全球冠狀動脈繞道手術手術市場的各種策略矩陣，將有助於相關人員做出決策。

公司簡介
- Abbott Laboratories
- Medtronic
- Boston Scientific Corporation
- LivaNova PLC
- Edwards Lifesciences Corporation
- Maquet Holding BV &Co. KG
- TERUMO CORPORATION
- Guidant
- Vitalitec
- Novadaq
- KARL STORZ
- Ethicon US, LLC（Johnson &Johnson）
- NeoGraft Technologies, Inc.
- Genesee Biomedical Inc.
- Hancock Jaffe Laboratories, Inc.
- VasoPrep Surgical
- Dextera Surgical Inc.
- Neograft Inc.

第10章分析師建議

命運之輪
分析師觀點
一致的機會圖

第11章參考文獻與調查方法

參考
調查方法

簡介目錄

Product Code: CMI7225

Global coronary artery bypass grafting market is estimated to be valued at USD 14.02 Bn in 2024 and is expected to reach USD 26.15 Bn by 2031, exhibiting a compound annual growth rate (CAGR) of 9.3% from 2024 to 2031.

Report Coverage		Report Details
Base Year:	2023	Market Size in 2024:	US$ 14.02 Bn
Historical Data for:	2019 to 2023	Forecast Period:	2024 to 2031
Forecast Period 2024 to 2031 CAGR:	9.30%	2031 Value Projection:	US$ 26.15 Bn

Figure. Coronary Artery Bypass Grafting Market Share (%), By Region 2024

Coronary Artery Bypass Grafting Market - IMG1

Coronary artery bypass grafting (CABG) is a type of surgery that improves blood flow to the heart. It is used to treat people with severe coronary artery disease that has not responded well to other treatments. The main purpose of the surgery is to bypass narrow or blocked sections of the coronary arteries with healthy blood vessels, usually taken from the chest, arm, or leg of the patient. This improves blood flow and oxygen delivery to the heart muscle, thus, relieving symptoms of chest pain or pressure (angina) and reducing the risk of heart attack. Coronary artery bypass grafting is one of the most commonly performed cardiac surgeries worldwide.

Market Dynamics:

Global coronary artery bypass grafting market growth is driven by increasing prevalence of heart disease across both developing and developed nations. High blood pressure, diabetes, obesity and lack of physical activity has increased cardiovascular cases, thus, boosting demand for CABG procedures. Favorable reimbursement policies for cardiac treatments in developed countries and growing medical tourism in emerging economies can offer opportunities for market growth. However, development of innovative minimally invasive endovascular techniques for coronary revascularization can hamper the market growth as these result in less complications and faster recovery times as compared to open-chest CABG surgery. The market players could overcome this restraint by integrating robotic and navigation technologies to make CABG safer and less complex.

Key Features of the Study:

This report provides in-depth analysis of the global coronary artery bypass grafting market, and provides market size (USD Billion) and compound annual growth rate (CAGR%) for the forecast period (2024-2031), considering 2023 as the base year

It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market

This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players

It profiles key players in the global coronary artery bypass grafting market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies

Key companies covered as a part of this study include Medtronic, Terumo, MAQUET, Boston Scientific, C. R. Bard and Edwards Lifesciences

Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics

Global coronary artery bypass grafting market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global coronary artery bypass grafting market

Detailed Segmentation-

By Technology
- Off-pump CABG
- On-pump CABG
- Others
By Product
- Grafts
- Saphenous vein grafts
- Internal thoracic artery grafts
- Other grafts
- Retractors
- Heart positioners
- Tissue stabilizers
- Others
By End User
- Hospitals
- Cardiology Clinics
- Ambulatory surgical centers
- Academic & Research institute
- Other
By Region
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East
- Africa
Company Profiles:
- Abbott Laboratories
- Medtronic
- Boston Scientific Corporation
- LivaNova PLC
- Edwards Lifesciences Corporation
- Maquet Holding B.V. & Co. KG
- TERUMO CORPORATION
- Guidant
- Vitalitec
- Novadaq
- KARL STORZ
- Ethicon US, LLC (Johnson & Johnson)
- NeoGraft Technologies, Inc.
- Genesee Biomedical Inc.
- Hancock Jaffe Laboratories, Inc.
- VasoPrep Surgical
- Dextera Surgical Inc.
- Neograft Inc.

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Market Snapshot, By Technology
- Market Snapshot, By Product
- Market Snapshot, By End User
- Market Snapshot, By Region

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
- Drivers
- Restraints
- Opportunities
Impact Analysis
Market Trends
Key Developments
Regulatory Scenario
Acquisitions and Partnerships Scenario
Funding and Investments
PEST Analysis
Porter's Analysis

4. Global Coronary Artery Bypass Grafting Market- Impact of Coronavirus (COVID-19) Pandemic

Overall Impact
Government Initiatives
COVID-19 Impact on the Market

5. Global Coronary Artery Bypass Grafting Market, By Technology, 2019 - 2031, (USD Bn)

Overview
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2019 - 2031
- Segment Trends
Off-pump CABG
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
On-pump CABG
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Others
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)

6. Global Coronary Artery Bypass Grafting Market, By Product, 2019 - 2031, (USD Bn)

Overview
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2019 - 2031
- Segment Trends
Grafts
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Saphenous vein grafts
Internal thoracic artery grafts
Other grafts
Retractors
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Heart positioners
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Tissue stabilizers
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Others
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)

7. Global Coronary Artery Bypass Grafting Market, By End User, 2019 - 2031, (USD Bn)

Overview
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2019 - 2031
- Segment Trends
Hospitals
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Cardiology Clinics
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Ambulatory surgical centers
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Academic & Research institute
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Others
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)

8. Global Coronary Artery Bypass Grafting Market, By Region, 2019 - 2031, (USD Bn)

Introduction
- Market Share Analysis, By Region, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, For Region, 2019-2031
- Regional Trends
  - North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Technology, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Product, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
  - U.S.
  - Canada
Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Technology, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Product, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USDBn)
  - Brazil
  - Mexico
  - Argentina
  - Rest of Latin America
Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Technology, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Product, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USDBn)
  - U.K.
  - Germany
  - Italy
  - France
  - Spain
  - Russia
  - Rest of Europe
Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Technology, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Product, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USDBn)
  - China
  - India
  - Japan
  - ASEAN
  - Australia
  - South Korea
  - Rest of Asia Pacific
Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Technology, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Product, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USDBn)
  - GCC Countries
  - Israel
  - Rest of Middle East
  - Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Technology, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Product, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2019 - 2031, (USDBn)
  - North Africa
  - Central Africa
  - South Africa

9. Competitive Landscape

Company Profiles
- Abbott Laboratories
  - Company Highlights
  - Method Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Medtronic
  - Company Highlights
  - Method Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Boston Scientific Corporation
  - Company Highlights
  - Method Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- LivaNova PLC
  - Company Highlights
  - Method Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Edwards Lifesciences Corporation
  - Company Highlights
  - Method Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Maquet Holding B.V. & Co. KG
  - Company Highlights
  - Method Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- TERUMO CORPORATION
- Guidant
- Vitalitec
- Novadaq
- KARL STORZ
- Ethicon US, LLC (Johnson & Johnson)
- NeoGraft Technologies, Inc.
- Genesee Biomedical Inc.
- Hancock Jaffe Laboratories, Inc.
- VasoPrep Surgical
- Dextera Surgical Inc.
- Neograft Inc.